Obesity and Hypertension. Manish Sinha Evelina London Children s Hospital

Size: px
Start display at page:

Download "Obesity and Hypertension. Manish Sinha Evelina London Children s Hospital"

Transcription

1 Obesity and Hypertension Manish Sinha Evelina London Children s Hospital Manchester 30 th June 2017

2 Scope of Talk Trends of childhood obesity in the UK Prevalence of hypertension in obese children Pathophysiology of hypertension in obesity Relevance does it matter during childhood and as young adults with childhood onset obesity Cases from our hypertension clinic

3 Definition of obesity - BMI There are several definitions around for overweight and obesity Clinical cut-offs - 85 th and 95 th percentile Health policy - 91 st and 98 th percentile (NICE/ DoH) International Obesity Task force (IOTF) - 88 th /90 th and 99 th corresponds with adult BMI cut offs at 25 kg/m 2 and 30 kg/m 2

4

5 Prevalence of overweight and obesity by study year and age group in boys and girls Cornelia H M van Jaarsveld, and Martin C Gulliford Arch Dis Child 2015;100:

6 Trends in childhood obesity Stabilising of the prevalence of childhood overweight and obesity similar trends in the US, Netherlands and Australia Reasons in the UK public health campaigns <11 year olds Physical Education in schools Active School Travel policies

7 Prevalence of obesity by study year and age group in boys and girls Cornelia H M van Jaarsveld, and Martin C Gulliford Arch Dis Child 2015;100:

8 and how common is hypertension in obese children?

9 Prevalence of hypertension and prehypertension in US (NHANES) Hypertension: SBP and/or DBP on 3 occasions 95 th percentile Prevalence 1-2%, age 8-17 Prehypertension: SBP and/or DBP 90 th percentile, < 95 th percentile or BP >120/80 mmhg Prevalence about 5% age % age 13-17

10 Prevalence of hypertension and prehypertension in US (NHANES) JAMA Pediatr. 2015;169(3): doi: /jamapediatrics

11 Hypertension in obese children-2 Sorof J et al. J Pediatr. 2002; 140:

12 Obese children display clustering of cardiometabolic risk factors In a cohort of n=611 obese youth hyperinsulinism (30.8%), lipid abnormalities (12.9%) and high BP (10.5%) in addition to obesity, one risk factor was present in 39%, two risk factors in 16.5% and three risk factors in 2.8% Blood pressure in children and adolescents: current insights. Lurbe, Empar; Ingelfinger, Julie Journal of Hypertension. 34(2): , 2016.

13 Major issue - several OTHER problems Type 2 diabetes mellitus Dyslipidaemia Non-alcoholic fatty liver (steatohepatitis) Obstructive sleep apnea Orthopaedic problems

14 Frequency of systolic and diastolic hypertension ISH (SBP ³140 mm Hg and DBP <90 mm Hg) SDH (SBP ³140 mm Hg and DBP ³90 mm Hg) IDH (SBP <140 mm Hg and DBP ³90 mm Hg) % 16% 16% 20% 20% 11% < Age Franklin et al. Hypertension 2001;37:

15 Frequency of systolic and diastolic hypertension ISH (SBP ³140 mm Hg and DBP <90 mm Hg) SDH (SBP ³140 mm Hg and DBP ³90 mm Hg) IDH (SBP <140 mm Hg and DBP ³90 mm Hg) % 16% 16% 20% 20% 11% < Age Sorof et al. J Pediatr 2002;140: Franklin et al. Hypertension 2001;37:

16 Pathophysiology - 1 Blood pressure - balance between CO and peripheral resistance In adults - CO maintained but peripheral resistance goes up as arterioles have smooth muscle cells

17 Mechanisms that link obesity with peripheral vascular resistance Autonomic nervous system activation Renal mechanisms: impaired pressure natriuresis; RAS Hormones: insulin resistance, Leptin Endothelial dysfunction: a state of inflammation Pathophysiology - 2

18 Summary-1 Excess weight including obesity remain highly prevalent and continue to rise in those >11 years absence of any specific long term programme Hypertension in obesity is common but only one of several CV risk factors present in this cohort Often asymptomatic and this makes it difficult for the patient to understand no national blood pressure measurement programmes Pathophysiology of hypertension in obese children is poorly understood few recent data

19 Do obese hypertensive children exhibit TOD? Obesity increased clustering of CV risk factors Increased carotid intima medial thickness (cimt) and LVH described in children with essential hypertension cimt and LV mass correlate with blood pressure and BMI elevated BMI, SBP and serum triglyceride and LDL-C Berenson GS et al. N Engl J Med 1998;338:

20 The Journal of Clinical Hypertension Volume 18, Issue 7, pages

21

22 Value of current BMI and BP? Normal BMI and blood pressure tracks during childhood tracking Probability of overweight at age 35 y predicted from childhood BMI at the 95th percentile Similarly, abnormal BMI and BP have been shown to increase to higher percentiles over time Guo S S, and Chumlea W C Am J Clin Nutr 1999;70:145s- 148s

23 Value of current BP SBP and DBP tracking correlation coefficients against follow-up period Xiaoli Chen, and Youfa Wang Circulation. 2008;117: Copyright American Heart Association, Inc. All rights reserved.

24 Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors Juonala M et al. N Engl J Med 2011;365: Four prospective cohort studies Bogalusa Heart Study (BOGA) Muscatine Study (MUSC) Childhood Determinants of Adult Health (CDAH) study Cardiovascular Risk in Young Finns Study (YFS)

25

26

27 From: Isolated Systolic Hypertension in Young and Middle-Aged Adults and 31-Year Risk for Cardiovascular Mortality: The Chicago Heart Association Detection Project in Industry Study J Am Coll Cardiol. 2015;65(4): doi: /j.jacc Figure Legend: Hypertension Subtype and Cardiovascular Mortality: Kaplan-Meier Curves of the Cumulative Incidence of CVD Mortality by Sex Sex-specific cumulative incidence rate of cardiovascular disease (CVD) mortality for each hypertension subtype is shown. The definition of each color line is as follows: periwinkle, systolic diastolic hypertension (systolic blood pressure [SBP] 140 mm Hg and diastolic blood pressure [DBP] 90 mm Hg); gold, isolated diastolic hypertension (SBP <140 mm Hg and DBP 90 mm Hg); violet, isolated systolic hypertension (SBP 140 mm Hg and DBP <90 mm Hg); green, high-normal blood pressure (BP) (SBP 130 to 139 Date mmof Hg download: and DBP 85 to 89 mm Hg, SBP 130 Copyright to 139 mm The Hg American and DBP <85 College mm Hg, of Cardiology. or SBP <130 mm Hg and DBP 85 to 89 mm Hg); 5/25/2015 salmon, optimal-normal BP (SBP <130 mm Hg and DBP All <85 rights mm reserved. Hg). The log-rank was used to calculate p values. IDH = isolated diastolic hypertension; ISH = isolated systolic hypertension; SDH = systolic diastolic hypertension.

28 Summary-2 Current BMI and BP levels - track and predict There is strong association of obesity and hypertension with surrogate markers of CV disease during childhood and Young obese adults with childhood onset obesity display the highest risk of developing CV risk factors Emerging longitudinal data regarding CV mortality related to elevated BP levels in young adults

29 Tertiary One stop hypertension clinic for service evaluation at ELCH of since June 2009 hypertension in children - single visit 90% with normal renal function Family history & investigation work-up completed Out of office evaluation including interpretation of results dietary assessment for salt and calories 24-hour urine specimen for measurement of sodium cardiac (and vascular) assessment monitoring following commencement of therapy shared care management 29

30 Tertiary clinic-2 The service is now well established with over 450 patients seen in the past 7-years see new referrals per year Patients being referred from primary, secondary primary care - General Practitioners - rarely secondary care Consultant Paediatricians majority tertiary care Consultant sub-specialists (cardiologist, endocrine) What are their age ranges? 14% <2years; 11% 2-5 years; 75% >5years

31 Case 1 DO 12 year old boy, african origin - headaches & chest pain No cardiac cause identified hence referred to the clinic cm (2 nd -9 th percentile) and 42.7 kg (75 th percentile) BMI 23.2 kg/m 2 (95 th percentile) clinical excess weight 126/78 mmhg clinic (95 th percentile 119/78) - confirmed on ambulatory BP 126/67 mmhg - ISH concentric LVH with increased microalbuminuria 7g of sodium in 24-hour urine specimen

32 Case 1 DO Future management Commenced on amlodipine whilst actively modifying lifestyle & diet 12 months later BP 112/70 mmhg asymptomatic but now performing regular physical exercise cm and 46kg - BMI 24.0 kg/m 2 (97 th percentile) Very few snacks - 5g equivalent of sodium in 24- hour urine LVMI improved 44 g/m 2.7

33 Normal blood pressure values for boys Height percentile 50 th 75 th 90 th 95 th 12 year 95 th BP percentile 13 year 95 th BP percentile 123/81 125/82 127/82 127/83 126/81 128/82 129/83 130/83

34

35

36 Staging of Hypertension Stage 1: 95 th 99 th percentile Stage 2: >99 th percentile +5mmHg Clinical urgency symptomatic or incidental finding? Life threatening hypertension 36

37 Improve clinical practice - 1 Must measure BP in children >3 years Copies of the normal BP tables in boys and girls from the Fourth report, should be available to all clinicians in clinic rooms Cardio Z iphone app from ELCH calculation of a user-defined 'target centile' blood pressure

38 Case 1 DO 2017 Ongoing weight gain and ill-sustained lifestyle changes Amlodipine and Lisinopril 4 years later BP 130/72 mmhg asymptomatic cm and 62.8kg - BMI 26.9 kg/m 2 (98 th percentile) - no change few snacks on history Increased indexed LV mass 65.6 g/m 2.7 ; concentric LVH

39 Case 2 NW 16 years 2 monh old boy, african origin feels unwell, headache 177 cm (25 th -50 th percentile) and 75 kg; BMI: 23.9 kg/m 2 (92 nd percentile) - clinical excess weight 170/62 mmhg clinic; (95 th percentile 136/86) confirmed on ambulatory BP 142/64 mmhg - ISH 7.9g of sodium in 24-hour eccentric LVH with increased microalbuminuria

40 Case 2 NW Future management - 9 months later Initially on two but now on single agent - ACEi - BP 122/64 mmhg - asymptomatic Modified diet - no snacks, family modified diet

41

42

43 Case 3 PM 15 year old girl, Caucasian headaches and breathlessness High BP detected whilst on holiday cm (50 th percentile) and 96.2 kg BMI: 31.8 kg/m2 (99 th percentile) - obese 143/104 mmhg clinic; (95 th percentile 131/80) confirmed on ambulatory BP 142/68 mmhg - ISH 12.5g of sodium in 24-hour; normal renal function no evidence of LVH; indexed LV mass 26.8 g.m2.7

44 Case 3 PM Family history of hypertension and hypercholesterolaemia normal lipid profile Difficult to convince need to take medications will take medications for short period and stop once BP level better! Good response to medications but no weight improvement or change in diet

45 Daily recommended salt in children 1 to 3 years 2g salt a day (0.8g sodium) 4 to 6 years 3g salt a day (1.2g sodium) 7 to 10 years 5g salt a day (2g sodium) 11 years and over 6g salt a day (2.4g sodium) Food labels only give the figure for sodium Salt (mg)= sodium (mg) x 2.5

46 Salt intake and blood pressure Quanhe Yang et al. Pediatrics 2012;130:

47 Case 4 DA 15 year old boy, african origin asymptomatic High BP detected when joining gymnasium cm and kg BMI: 29.7 kg/m2 (99 th percentile) obese Hyperuricaemia and dyslipidaemia 159/77 mmhg clinic; confirmed on ambulatory BP 154/92 mmhg - SDH 11.5g of sodium in 24-hour; normal renal function Concentric LVH; indexed LV mass 46.6 g.m2.7 Commenced on Amlodipine with some improvement Felt better - so stopped medication and missed two appointments!

48 Weight (Kg) Blood pressure (mmhg) Case 4 DA Weight SBP DBP Re-presented with even worse BP 163/100 mmhg o asymptomatic cannot understand the fuss; weight 119.8kg Continuing poor adherence to diet and medication Transitioned to adults - no change o o o Age in years Asymptomatic; 132.1kg and increasing; BMI 99 th percentile Concentric LVH but with preserved biventricular systolic function On 3-anti-hypertensives (Amlodipine, Lisinopril and Hydrochorthiazide)

49 Case 5 JB 16 years 9 months boy, causcasian intermittent headaches High BP detected at the time of check entry to health club DGH - height (50 th -75 th centile) and weight 119 kg BMI 38.1 kg/m 2 (>99 th percentile) morbidly obese 160/86 mmhg - confirmed on ABPM 151/74 mmhg - ISH HTN clinic kg! and BP improved as well!! Clinic - 124/62 mmhg clinic; ambulatory BP 110/66 mmhg on no medication No evidence of LVH

50 Case 5 JB Future management Took up boxing 18 months later 83.5kg & very well - discharged Dynamap 143/71 but Aneroid measurements 112/68 mmhg

51 Management Non-pharmacological: weight reduction and exercise together most effective at least early (>6-month) compliance major issue target BMI <85 th percentile, 40-min exercise 3-5 days a week Diet need to cut down on salt intake This needs to be demonstrated to families often as convinced salt intake not high! Pharmacotherapy generally reserved for symptomatic hypertension +/- evidence of end-organ damage elevated BP unresponsive to conservative treatment 51

52 Summary-3 some findings from the hypertension clinic Isolated systolic hypertension 80%-85% males, adolescents, increased BMI and poor diet No identifiable cause renal, cardiac, other mostly asymptomatic; High salt intake and excessive sodium in 24-hour urine even in those with normal BMI In confirmed cases of hypertension less than a 1/3 rd have LVH (+/-micro Alb) often eccentric Most effective treatment measures that have improved BP Reduction of salt intake CCB, ACEi and diuretics in some 52

53 Acknowledgments Kings College London Guy s & St Thomas Charity British Heart Foundation 53

54 THANK YOU

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center

Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center Adolescent Hypertension Roles of obesity and hyperuricemia Daniel Landau, MD Pediatrics, Soroka University Medical Center Blood Pressure Tables BP standards based on sex, age, and height provide a precise

More information

Reference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents

Reference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents Reference Values and Simplified Methods for Interpretation of Blood Pressure in Children and Adolescents Simonetti G.D. Istituto Pediatrico della Svizzera Italiana Ente Ospedaliero Cantonale e Università

More information

Egyptian Hypertension Guidelines

Egyptian Hypertension Guidelines Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich

More information

Dr Doris M. W Kinuthia

Dr Doris M. W Kinuthia Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

Fructose, Uric Acid and Hypertension in Children and Adolescents

Fructose, Uric Acid and Hypertension in Children and Adolescents Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD Metabolic Syndrome Across the Life Cycle - Adolescent Joy Friedman MD Disclosures I have no actual or potential conflict of interest in relation to this program or presentation. I will mention off-label

More information

Assessing Overweight in School Going Children: A Simplified Formula

Assessing Overweight in School Going Children: A Simplified Formula Journal of Applied Medical Sciences, vol. 4, no. 1, 2015, 27-35 ISSN: 2241-2328 (print version), 2241-2336 (online) Scienpress Ltd, 2015 Assessing Overweight in School Going Children: A Simplified Formula

More information

What is hypertension?

What is hypertension? HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

Importance of Ambulatory Blood Pressure Monitoring in Adolescents Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud

More information

major public health burden

major public health burden HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing

More information

Adolescent Obesity GOALS BODY MASS INDEX (BMI)

Adolescent Obesity GOALS BODY MASS INDEX (BMI) Adolescent Obesity GOALS Lynette Leighton, MS, MD Department of Family and Community Medicine University of California, San Francisco December 3, 2012 1. Be familiar with updated obesity trends for adolescent

More information

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016 The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

Reframe the Paradigm of Hypertension treatment Focus on Diabetes Reframe the Paradigm of Hypertension treatment Focus on Diabetes Paola Atallah, MD Lecturer of Clinical Medicine SGUMC EDL monthly meeting October 25,2016 Overview Physiopathology of hypertension Classification

More information

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence JNC 7 Is Nice But What s Up With JNC 8? 37 th Annual CAPA Conference October 4 th 2013 Ignacio de Artola, Jr. M.D. Assistant Professor of Clinical Family Medicine Medical Director, Primary Care Physician

More information

MPharmProgramme. Hypertension (HTN)

MPharmProgramme. Hypertension (HTN) MPharmProgramme Hypertension (HTN) Slide 1 of 30 Overview Definition Prevalence Type Causes Diagnosis Management Patients perspective Slide 2 of 30 Definition It is not a disease! So what is it? What two

More information

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult

More information

The Association of Pediatric Obesity with Nocturnal Non-Dipping on. 24-Hour Ambulatory Blood Pressure Monitoring. Ian Macumber.

The Association of Pediatric Obesity with Nocturnal Non-Dipping on. 24-Hour Ambulatory Blood Pressure Monitoring. Ian Macumber. The Association of Pediatric Obesity with Nocturnal Non-Dipping on 24-Hour Ambulatory Blood Pressure Monitoring Ian Macumber A thesis submitted in partial fulfillment of the requirements for the degree

More information

Hypertension in the very old. Objectives: Clinical Perspective

Hypertension in the very old. Objectives: Clinical Perspective Harvard Medical School Hypertension in the very old Ihab Hajjar, MD, MS, AGSF Associate Director, CV Research Lab Assistant Professor of Medicine, Harvard Medical School Objectives: Describe the clinical

More information

Combination Therapy for Hypertension

Combination Therapy for Hypertension Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP

More information

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN** Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits

More information

Pediatric Hypertension. Alisa A. Acosta, MD, MPH Asst. Professor, Renal Section April 5, 2019

Pediatric Hypertension. Alisa A. Acosta, MD, MPH Asst. Professor, Renal Section April 5, 2019 Pediatric Hypertension Alisa A. Acosta, MD, MPH Asst. Professor, Renal Section April 5, 2019 Objectives Recognize the importance of accurate blood pressure measurement in pediatric patients Define pediatric

More information

Objectives. Describe results and implications of recent landmark hypertension trials

Objectives. Describe results and implications of recent landmark hypertension trials Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

Blood Pressure Measurement (children> 3 yrs)

Blood Pressure Measurement (children> 3 yrs) Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic

More information

Prevention of Heart Failure: What s New with Hypertension

Prevention of Heart Failure: What s New with Hypertension Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal

More information

Hypertension Guidelines 2017

Hypertension Guidelines 2017 Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,

More information

Hypertension and Cardiovascular Disease

Hypertension and Cardiovascular Disease Hypertension and Cardiovascular Disease Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic,

More information

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University Management of Hypertension in special groups BY DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University AGENDA SPECIAL GROUPS SPECIFIC DRUDS FOR SPECIAL GROUPS TARGET BP FOR SPECIAL GROUPS:

More information

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of

More information

None. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:

None. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to: 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) James W. Shaw, MD Memorial Lecture

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study

Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study Keystone, Colorado, July 2013 Practical Ways to Achieve Targets in Diabetes Care Adolescent renal and cardiovascular disease protection in type 1 diabetes AdDIT Study Professor David Dunger Department

More information

Cedars Sinai Diabetes. Michael A. Weber

Cedars Sinai Diabetes. Michael A. Weber Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor

More information

Five chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical

More information

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured. Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.

More information

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Management of Hypertension. Ahmed El Hawary MD Suez Canal University Management of Hypertension Ahmed El Hawary MD Suez Canal University Minimal vs. Optimal Care Resources more than science affect type of care and level of management. what is possible (minimal care) and

More information

OBESITY IN PRIMARY CARE

OBESITY IN PRIMARY CARE OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading

More information

Cardiometabolic Side Effects of Risperidone in Children with Autism

Cardiometabolic Side Effects of Risperidone in Children with Autism Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin

More information

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Hypertension targets: sorting out the confusion Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Historical Perspective The most famous casualty of this approach was the

More information

Treating Hypertension in 2018: What Makes the Most Sense Today?

Treating Hypertension in 2018: What Makes the Most Sense Today? Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

Page 1. Disclosures. Background. No disclosures

Page 1. Disclosures. Background. No disclosures Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen

More information

Center for healthy weight and Nutrition. Primary Care Pocket Guide to. Pediatric Obesity Management

Center for healthy weight and Nutrition. Primary Care Pocket Guide to. Pediatric Obesity Management Center for healthy weight and Nutrition Primary Care Pocket Guide to Pediatric Obesity Management Introduction The Primary Care Pocket Guide to Pediatric Obesity Management is intended to provide primary

More information

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August

More information

HYPERTENSION: ARE WE GOING TOO LOW?

HYPERTENSION: ARE WE GOING TOO LOW? HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,

More information

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

Evaluation and Treatment of Childhood Obesity

Evaluation and Treatment of Childhood Obesity Evaluation and Treatment of Childhood Obesity Stephen R. Daniels, MD, PhD Department of Pediatrics University of Colorado School of Medicine and Children s Hospital Colorado In 1953, Morris et al compared

More information

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases

Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Optimizing Postpartum Maternal Health to Prevent Chronic Diseases Amy Loden, MD, FACP, NCMP Disclosures Research: None Financial: none applicable to this presentation PRIUM QEssentials Market Research

More information

Update on Current Trends in Hypertension Management

Update on Current Trends in Hypertension Management Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student

More information

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

University of Padova, Padua, Italy, and HARVEST Study Group, Italy University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini

More information

From the desk of the: THE VIRTUAL NEPHROLOGIST

From the desk of the: THE VIRTUAL NEPHROLOGIST Hypertension, also referred to as high blood pressure or HTN, is a medical condition in which the blood pressure is chronically elevated. It is a very common illness. One out of three American adults has

More information

Chronic Pediatric Hypertension

Chronic Pediatric Hypertension Chronic Pediatric Hypertension Nephrology Grand Round 3/13/2015 Mahmoud Kallash M.D Outline Definition of hypertension (HTN) Challenges in diagnosing HTN Epidemiology Causes and evaluation of HTN Management

More information

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME What does the term Metabolic Syndrome describe? Metabolic syndrome describes a cluster of cardio-metabolic conditions that increase one's risk of developing

More information

Effective Date: TBD Version: 1.0 (Revised: 6/11/2014)

Effective Date: TBD Version: 1.0 (Revised: 6/11/2014) Protocol Title: Hypertension Effective Date: TBD Version: 1.0 (Revised: 6/11/2014) Approval By: TBD Planned Review Date: TBD 1 Purpose & Objective This protocol provides evidence-based care recommendations

More information

Cardiovascular Diseases in CKD

Cardiovascular Diseases in CKD 1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Janice P. Lea, MD, MSc, FASN Professor of Medicine Chief Medical Director of Emory Dialysis ASH Clinical Specialist

More information

Overview. NOT A REPETION OF LOCAL GUIDELINE Dr Diviash Thakrar

Overview. NOT A REPETION OF LOCAL GUIDELINE Dr Diviash Thakrar Overview 1. Why hypertension is important? 2. What are basic principles in treatment? 3. Different ways of measuring 4. Hypercholesterolemia NOT A REPETION OF LOCAL GUIDELINE CVD risk factors? Non modifiable

More information

Management of High Blood Pressure in Children and Adolescents

Management of High Blood Pressure in Children and Adolescents Π.Μ.Σ. «ΜΟΝΑΔΕΣ ΕΝΤΑΤΙΚΗΣ ΘΕΡΑΠΕΙΑΣ - ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣΗΛΕΥΤΙΚΗ» Management of High Blood Pressure in Children and Adolescents ΕΠΙΔΡΑΣΗ ΤΗΣ ΑΝΤΙΥΠΕΡΤΑΣΙΚΗΣ ΑΓΩΓΗΣ ΣΤΗΝ ΑΡΤΗΡΙΑΚΗ ΣΚΛΗΡΙΑ ΥΠΕΡΤΑΣΙΚΩΝ ΑΣΘΕΝΩΝ

More information

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati CHAPTER-I CARDIOVASCULAR SYSTEM Hypertension SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati Hypertension

More information

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment

More information

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs

More information

GDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity

GDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity GDF-15 levels but not NTproBNP levels predict diastolic heart failure in morbid obesity M. Fischer, C. Strack, J. Bruxmeier, F. Wagner, E. Rousseva, G. Schmitz, G. Riegger, A. Baessler Clinic for Internal

More information

Hypertension Update Background

Hypertension Update Background Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison

More information

Study of Serum Hepcidin as a Potential Mediator of the Disrupted Iron Metabolism in Obese Adolescents

Study of Serum Hepcidin as a Potential Mediator of the Disrupted Iron Metabolism in Obese Adolescents Study of Serum Hepcidin as a Potential Mediator of the Disrupted Iron Metabolism in Obese Adolescents Prof. Azza Abdel Shaheed Prof. of Child Health NRC National Research Centre Egypt Prevalence of childhood

More information

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University

More information

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY JOSHUA K. KAYIMA ASSOCIATE PROFESSOR DEPT. OF CLINICAL MEDICINE AND THERAPEUTICS UNIVERSITY OF NAIROBI Introduction According to

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM

LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM LONG-TERM EFFECTS OF SURGICAL MENAGEMENT OF PRIMARY ALDOSTERONISM ON THE CARDIOVASCULAR SISTEM Riccardo Marsili, Pietro Iacconi, Massimo Chiarugi, Giampaolo Bernini*, Alessandra Bacca*, Paolo Miccoli Department

More information

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing

More information

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing

Hypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/

More information

«Πατσζαρκία και Καρδιαγγειακή Νόζος»

«Πατσζαρκία και Καρδιαγγειακή Νόζος» «Πατσζαρκία και Καρδιαγγειακή Νόζος» Δημήτρης Π. Παπαδόπουλος-FESC Clinical Assist. Professor George Washington University USA Επιμελητής Καρδιολογικής Κλινικής Π.Γ.Ν.Α. «ΛΑΪΚΟ» Υπεύθυνος Αντιυπερτασικού

More information

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose. JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I

More information

Inclusion Criteria: 3 years of age and have had at least 2 visits in the last year Exclusion Criteria: BMI 85 th percentile

Inclusion Criteria: 3 years of age and have had at least 2 visits in the last year Exclusion Criteria: BMI 85 th percentile Inclusion Criteria: 3 years of age and have had at least 2 visits in the last year Exclusion Criteria: BMI 85 th percentile Document the Measurement of Blood Pressure (BP) 90% of patients diagnosed with

More information

Mesures non médicamenteuses pour prévenir et traiter une hypertension artérielle. JM Krzesinski Service de Néphrologie- Hypertension ULg-CHU Liège

Mesures non médicamenteuses pour prévenir et traiter une hypertension artérielle. JM Krzesinski Service de Néphrologie- Hypertension ULg-CHU Liège Mesures non médicamenteuses pour prévenir et traiter une hypertension artérielle JM Krzesinski Service de Néphrologie- Hypertension ULg-CHU Liège Disclosure No competing interest to declare about this

More information

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between

More information

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina

More information

Hypertension Update. Aaron J. Friedberg, MD

Hypertension Update. Aaron J. Friedberg, MD Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Wessex Paediatric Oncology Supportive Care Guidelines: Management of Hypertension.

Wessex Paediatric Oncology Supportive Care Guidelines: Management of Hypertension. Wessex Paediatric Oncology Supportive Care Guidelines: Management of Hypertension. Scope This guideline applies to all paediatric oncology patients in the region. It does not apply to neonates on neonatal

More information

Preventing and Treating High Blood Pressure

Preventing and Treating High Blood Pressure Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure

More information

Blood Pressure Acre Surgery Diviash Thakrar

Blood Pressure Acre Surgery Diviash Thakrar Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise

More information

Conflict of Interest Disclosure Obesity Treatment: What Is a Staged Approach & What Does it Mean for Clinicians?

Conflict of Interest Disclosure Obesity Treatment: What Is a Staged Approach & What Does it Mean for Clinicians? Conflict of Interest Disclosure Obesity Treatment: What Is a Staged Approach & What Does it Mean for Clinicians? Nothing to declare Nancy F. Krebs, MD, MS University of Colorado Denver School of Medicine

More information

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS? HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL

More information